Fermenta Biotech shareholding pattern

FERMENTA

301.1

5.40 (1.83%)
Last updated on 1 Jun, 2026 | 15:31 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Fermenta Biotech Shareholding Pattern

  • 2016-17
  • 2020-21
  • 2021-22
  • 2022-23
  • 2025-26
  • 2026-27
  • 2024-25
  • 2023-24
  • 2019-20
  • 2018-19
Total Promoters
Segment
Percent

Total Promoters

59.58%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0.01%

Retail

40.41%

Others

0%

Total Promoters
MAR '22
59.58%
JUN '22
59.58%
SEP '22
59.58%
DEC '22
59.58%

Summary

Fermenta Biotech share holding pattern reports the following shareholding: Fermenta Biotech Total Promoters is at 64.09%, Mutual Fund at 0.00%, Insurance at 0.00%, Foreign Institutional Investors at 0.02%, Domestic Institutional Investors at 0.00%, and Retail at 35.89%. This breakdown provides a quick snapshot of ownership distribution for Fermenta Biotech share holding pattern in 2026-27.

Fermenta Biotech FAQs

As of 06-2026, the promoter shareholding in Fermenta Biotech stands at 64.09% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Fermenta Biotech is 0.02% and 0% respectively.

The retail shareholding of the Fermenta Biotech is 35.89%.

Changes in shareholding patterns of Fermenta Biotech can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Fermenta Biotech are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost